Amir A. Al-Khami, Ph.D. Dr. Al-Khami completed PhD in tumor immunology under a program between Tanta University Egypt and The Medical University of South Carolina in 2009. His dissertation established some of the mechanisms by which lymphodepletion enhances adoptive T cell therapy of cancer. Following PhD, Dr. Al-Khami accepted a postdoctoral fellowship in the laboratory of Dr. Shikhar Mehrotra at The Medical University of South Carolina in 2010. He studied the activation-induced cell death in tumor-reactive CD8+ T cell subsets, in addition to a novel transgenic mouse model of cancer, which was developed in the laboratory using a human tyrosinase epitope-reactive T cell receptor. In 2012, Dr. Al-Khami accepted a second postdoctoral fellowship in the laboratory of Dr. Augusto Ochoa at LSU Health Sciences Center to study the role of energy metabolic reprogramming in tumor-associated myeloid-derived suppressor cells.

PubMed

.

.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .